Percutaneous Device Closure of Patent Ductus Arteriosus with Pulmonary Artery Hypertension: Long-Term Results

2014 ◽  
Vol 27 (6) ◽  
pp. 563-569 ◽  
Author(s):  
ISHWARAPPA BALEKUNDRI VIJAYALAKSHMI ◽  
NATRAJ SETTY ◽  
CHITRA NARASIMHAN ◽  
VIVEK SINGLA ◽  
CHOLENAHALLI NANJAPPA MANJUNATH
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Pulmonary Artery Hypertension ◽  
Long Term Results ◽  
Device Closure ◽  
Percutaneous Device ◽  
Percutaneous Device Closure ◽  
Patent Ductus

Ductal arterial spasm: a nightmare

2020 ◽  
Vol 30 (3) ◽  
pp. 422-423
Author(s):  
Hnin L. Phyu ◽  
Khin M. Oo
Keyword(s):  
Patent Ductus Arteriosus ◽  
Transcatheter Closure ◽  
Ductus Arteriosus ◽  
Catheter Intervention ◽  
Device Closure ◽  
Arterial Spasm ◽  
Percutaneous Device ◽  
Device Selection ◽  
Percutaneous Device Closure ◽  
Patent Ductus

AbstractDuctal arterial spasm is a very potentially dangerous incidence during percutaneous device closure of patent ductus arteriosus (PDA), which, otherwise, is a very safe catheter intervention. It is essential to notice its occurrence before device sizing and deploying. Without awareness, it can mislead device selection and can result in serious complication. In this report, we shared our nightmare of ductal spasm during transcatheter closure of PDA in two children which had led to death in one patient.

scholarly journals Percutaneous device closure of patent ductus arteriosus in adult patients with 10-year follow-up

Heart Views ◽  
2019 ◽  
Vol 20 (4) ◽  
pp. 139
Author(s):  
Wail Alkashkari ◽  
Saad Albugami ◽  
Jamilah Alrahimi ◽  
Mohammed Althobaiti ◽  
Abdulhalim Kinsara ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Adult Patients ◽  
Device Closure ◽  
Percutaneous Device ◽  
Percutaneous Device Closure ◽  
Patent Ductus

Late manifestation coarctation of the aorta in a premature infant 4-month post-percutaneous device closure of a patent ductus arteriosus

2019 ◽  
Vol 29 (12) ◽  
pp. 1556-1558
Author(s):  
Ryan M. Serrano ◽  
Mark D. Rodefeld ◽  
Ryan Alexy
Keyword(s):  
Patent Ductus Arteriosus ◽  
Premature Infants ◽  
Ductus Arteriosus ◽  
Coarctation Of The Aorta ◽  
Percutaneous Closure ◽  
Device Closure ◽  
Percutaneous Device ◽  
Favourable Safety ◽  
Patent Ductus

AbstractPatent ductus arteriosus is the most common cardiovascular abnormality in premature infants. With newly available percutaneous devices, centres are reporting high rates of success and favourable safety profiles with percutaneous closure of haemodynamically significant ductus arteriosi in infants under 1000 g. We report the case of a 5-week-old, previous 25-week gestation, 1200-g infant who underwent successful percutaneous closure of a ductus arteriosus with a Medtronic Microvascular Plug but who developed late-term coarctation from the device. This case should prompt practitioners to consider the need and timing of follow-up echocardiograms in this population and sheds light on a newly reported long-term complication of device closure in premature infants.

scholarly journals MANAGEMENT OF HYPERTENSIVE PDA

2021 ◽  
Vol 70 (Suppl-4) ◽  
pp. S701-05
Author(s):  
Khushal Khan Khattak ◽  
Maad Ullah ◽  
Abdul Malik Sheikh ◽  
Asma Kanwal ◽  
Sajid Ali Shah ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Palliative Treatment ◽  
Ductus Arteriosus ◽  
Treatment Options ◽  
Device Closure ◽  
Surgical Ligation ◽  
Percutaneous Catheter ◽  
Patent Ductus

Objective: To determine different treatment options in patients of Patent Ductus Arteriosus with pulmonary hypertension beyond neonatal period. Study Design: Descriptive cross sectional study. Place and Duration of Study: This study was carried out in Pediatric Cardiology department of Rawalpindi Institute of Cardiology, from Jan 2017 to Jan 2019. Methodology: Patients having PDA with pulmonary hypertension were included in the study. Treatment options were divided into percutaneous catheter device closure, surgical ligation of patent ductus arteriosus and palliative treatment. Any adverse event during the procedure was documented. Stratification was done in regard to gender and age group. Post stratification chi square test was applied and p-value less than or equal to 0.05 was considered as significant. Results: Total number of patients included in the study were 37. Mean age (years) of patients (Mean ± SD) was 19.21 ± 8.76. Mean ± SD pulmonary artery pressure was 56.43 ± 11.55 mmHg. Percutaneous catheter device closure was successful in 24 (64.9%) patients, in 7 (18.9%) patients primary surgical PDA ligation was done, 3 (8.1%) patients were advised palliative treatment and in 3 (8.1%) patients adverse events occurred during percutaneous device closure and were thus referred for surgical ligation. Patent ductus Arteriosus Occlutech device was used in 18 (48.6%) patients, Occlutech VSD device was used in 7 (18.5%) patients and in 1 (2.7%) patient AGA duct occluder was used. Conclusion: In patients with patent ductus arteriosus and pulmonary artery hypertension, percutaneous catheter device closure is a safe and effective procedure.

Sign in / Sign up

Export Citation Format

Share Document